9 completed, 8 unknown, 4 recruiting, 1 active not recruiting. 14 Not applicable, 1 Early Phase 1, 1 Phase 1, 1 Phase 3, 1 Phase 4.
Follow Diabetes type2: new trials by email Literature Review of Diabetes type2 trials Research Report on Diabetes type2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Benefits of Nutritional Ingredients for Type 2 Diabetes Control: CHO Blend, Experimental: CHO Blend plus AN100 - Diabetes type2 | Not applicable | Withdrawn | Abbott Nutrition | 2024-09-01 | 2024-12-04 | |
| A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of D745, D759, and D150 D745, D759, D150 - Diabetes type2 | Phase 1 | Completed | Chong Kun Dang Pharmaceutical | 24 | 2023-07-10 | 2024-03-12 |
| Organisational Models Supported by Technology for the Management of Diabetic Disease and Its Complications in a Diabetic Clinic Setting. A Randomised Controlled Trial Targeting Type 2 Diabetes Individuals With Non-ideal Glycemic Values TreC Diabete App - Diabetes type2 | Not applicable | Unknown | Azienda Sanitaria Universitaria Integrata del Trentino | 120 | 2022-12-30 | 2023-07-20 |
| Training on Using ıInsulin in Patients With Type 2 Diabetes Insulin Dependent Diabetes, Diabetes type2 | Completed | Inonu University | 84 | 2022-10-01 | 2023-06-26 | |
| Time-Restricted Eating for Type II Diabetes: TRE-T2D Time-Restricted Eating, Standard of Care - Diabetes Mellitus, Type 2, Time Restricted Feeding | Not applicable | Active not recruiting | University of California, San Diego | 60 | 2022-05-16 | 2026-06-11 |
| Actiste® Diabetes Management as a Service (ADMS) Clinical Investigation Device: Actiste 1.0 and the Companion app with TBL Backend - Diabetes type1, Diabetes type2 | Not applicable | Completed | Northern Care Alliance NHS Foundation Trust | 13 | 2022-03-14 | 2025-05-23 |
| Impact of Obesity, Chronic Kidney Disease and Type 2 Diabetes on Human Urinary Stem Cells urine collection - Chronic Kidney Diseases, Obesity | Unknown | Hospices Civils de Lyon | 60 | 2021-11-01 | 2021-08-10 | |
| Acceptance and Commitment Therapy Principles for Diabetes Prevention Diabetes Prevention Education and Acceptance and Commitment Therapy, Diabetes Prevention Education Only - PreDiabetes, Diabetes Mellitus, Type 2 | Not applicable | Completed | University of Oregon | 301 | 2021-08-28 | 2022-03-02 |
| Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors Kidney Biopsy - Chronic Kidney Diseases, Albuminuria | Recruiting | Herlev Hospital | 300 | 2021-08-10 | 2025-12-24 | |
| Dietary Approaches to Stop Hypertension for Diabetes DASH4D diet, comparison diet, higher sodium - Diabetes Mellitus, Type 2, Diabetes | Not applicable | Completed | Johns Hopkins University | 105 | 2021-06-02 | 2026-05-13 |
| Digital Individualized and Collaborative Treatment of T2D in General Practice Based on Decision Aid Clinical decision support, Digital Lifestyle Coaching, Integration to Standard Electronic Health Record - Diabetes type2 | Not applicable | Recruiting | University of Southern Denmark | 400 | 2021-06-01 | 2025-09-02 |
| Intermittent Fasting to Improve Insulin Secretion Intermittent fasting, Control diet - PreDiabetes, Diabetes type2 | Not applicable | Recruiting | University Hospital Tuebingen | 200 | 2021-04-08 | 2026-04-21 |
| Primary Care Based Integrated Community Care Team Intervention PACE-It mobile application - Diabetes, Diabetes Mellitus | Not applicable | Terminated | SingHealth Polyclinics | 41 | 2020-12-07 | 2022-04-28 |
| Effect of Totum-63 on Glucose and Lipid Homeostasis in Subjects With Dysglycemia (REVERSE-IT) TOTUM-63 3 intakes per day, Placebo 3 intakes per day, TOTUM-63 2 intakes per day - Prediabetic State, Diabetes type2 | Not applicable | Completed | Valbiotis | 636 | 2020-07-08 | 2023-09-21 |
| 16-week Flexible vs. 8-week Semaglutide Titration Semaglutide, label recommended titration - Diabetes type2 | Phase 3 | Unknown | Tel-Aviv Sourasky Medical Center | 100 | 2020-02-23 | 2020-06-25 |
| NASH and Type 2 Diabetes: Role of the Receptor Activator of Nuclear Factor-κB (RANK) and Its Ligand (RANKL) "Collection of additional blood tubes; Biobanking (plasma, liver tissue). - Diabetes type2, NASH - Nonalcoholic Steatohepatitis | Unknown | Assistance Publique - Hôpitaux de Paris | 50 | 2020-02-01 | 2020-01-28 | |
| A Real World Research: Comparison of Precision and Experience Therapy for Hypertension, Diabetes or Hyperlipidemias Gene detection of therapeutic drugs for chronic cardiovascular and cerebrovascular diseases, Regular follow-up and patient education - Hypertension,Essential, Diabetes type2 | Not applicable | Unknown | Beijing Chao Yang Hospital | 1172 | 2020-01-21 | 2020-12-09 |
| The Occurence of Pancreatic Cancer Studied in Association With Newly Diagnosed Diabetes in the Elderly Diabetes Mellitus, Diabetes | Unknown | University of Pecs | 2522 | 2019-10-09 | 2023-04-19 | |
| The RESET System Pivotal Clinical Trial (Protocol Revision K) RESET Liner, Sham - Diabetes type2, Obesity | Not applicable | Recruiting | Morphic Medical Inc. | 264 | 2019-09-09 | 2026-10-13 |
| The Canadian Diabetes Prevention Program DPP Curriculum for Lifestyle Intervention - Diabetes type2 | Not applicable | Unknown | LMC Diabetes & Endocrinology Ltd. | 2174 | 2019-06-21 | 2023-03-24 |
Showing 20 of 24. Sign in to see all of them.
Diabetes Mellitus, Type 2 (7) · Diabetes Mellitus (5) · Obesity (3) · Prediabetic State (3) · Intermittent Fasting (2) · Renal Insufficiency, Chronic (2) · Albuminuria (1) · Diabetes Mellitus, Type 1 (1) · Diabetic Nephropathies (1) · Essential Hypertension (1) · Glucose Intolerance (1) · Hyperglycemia (1) · Hyperlipidemias (1) · Hypertension (1) · Non-alcoholic Fatty Liver Disease (1)
Nutritional and Metabolic Diseases (13) · Endocrine System Diseases (11) · Metabolic Diseases (11) · Glucose Metabolism Disorders (10) · Diabetes Mellitus (6) · Pathological Conditions, Signs and Symptoms (5) · Signs and Symptoms (5) · Body Weight (4) · Behavior (3) · Nutrition Disorders (3) · Overnutrition (3) · Overweight (3) · Cardiovascular Diseases (2) · Chronic Disease (2) · Digestive System Diseases (2)
Control Groups (1) · Fecal Microbiota Transplantation (1) · Patient Education as Topic (1) · Specimen Handling (1) · Standard of Care (1) · Transcutaneous Electric Nerve Stimulation (1) · Urine Specimen Collection (1) · Wearable Electronic Devices (1) · salicylhydroxamic acid (1) · semaglutide (1)
Abbott Nutrition (1) · Assistance Publique - Hôpitaux de Paris (1) · Azienda Sanitaria Universitaria Integrata del Trentino (1) · Beijing Chao Yang Hospital (1) · Cairo University (1) · Chong Kun Dang Pharmaceutical (1) · Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (1) · Herlev Hospital (1) · Hospices Civils de Lyon (1) · Inonu University (1) · Johns Hopkins University (1) · LMC Diabetes & Endocrinology Ltd. (1) · Morphic Medical Inc. (1) · Northern Care Alliance NHS Foundation Trust (1) · SingHealth Polyclinics (1)
United States (6) · China (2) · Denmark (2) · France (2) · Germany (2) · Hungary (2) · Italy (2) · Bulgaria (1) · Canada (1) · Egypt (1) · Israel (1) · Poland (1) · Romania (1) · Singapore (1) · South Korea (1)
Adrian Heald, Dr (1) · Christopher C Thompson, MD (1) · Dana Graves, DDS, DMSc (1) · Elizabeth Selvin, PhD (1) · Francisco J Tinahones, MD, PhD (1) · Frederik Persson, MD, PhD (1) · Hala MH Ezz-eldeen, Professor (1) · Hsin Chieh Yeh, PhD (1) · Lawrence Appel, MD, MPH (1) · Lihong Liu, Doctor (1)
PMID 15886696, PMID 16083707, PMID 17872573, PMID 19111249, PMID 21458985, PMID 21654538, PMID 24840647, PMID 26492440, PMID 26777407, PMID 28108468, PMID 33444177, PMID 35732151, PMID 37280026, PMID 37563665, PMID 37870928, PMID 40232790, PMID 40485759, PMID 40489102, PMID 40764427, PMID 42477326
R01DE026603 (1), R01DK128900 (1)